MedPath

Hypotension Prediction Index (HPI) in Patients Undergoing Robotic Assisted Radical Prostatectomy

Not Applicable
Completed
Conditions
Hypotension During Surgery
Interventions
Device: No Hypotension Prediction Index
Device: Hypotension Prediction Index
Registration Number
NCT06535464
Lead Sponsor
University of Foggia
Brief Summary

Robot assisted radical prostatectomy (RARP) is the leader in robotic treatment for prostate cancer. Goal-directed therapy (GDT) is the approach used, but HPI, a machine learning algorithm analysing arterial waveforms, might offer additional benefits. The aim of this prospective randomised study is to evaluate the cumulative amount of intraoperative arterial hypotension episodes in patients undergoing RARP managed by GDT protocol guided or not by HPI algorithm

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • all consecutive patients undergoing RARP; American Society of Anaesthesiology (ASA) SCORE I-III
Exclusion Criteria
  • Body Mass Index (BMI) of 18.5 to 35, uncontrolled arrhythmias, myocardial infarction or ischemic/hemorrhagic stroke in the last 6 months, III/IV stage Global Initiative for Chronic Obstructive Lung Disease, pulmonary fibrosis, contraindication to radial artery cannulation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Goal-directed therapy aloneNo Hypotension Prediction Index-
Goal-directed therapy guided by Hypotension Prediction Index algorithmHypotension Prediction Index-
Primary Outcome Measures
NameTimeMethod
cumulative amount of time spent in Hypotensionintraoperative

the cumulative amount of intraoperative hypotension, measured by Time Weighted Average (TWA) of Mean Arterial Pressure (MAP) below 65 mmHg

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ospedali Riuniti

🇮🇹

Foggia, Puglia, Italy

© Copyright 2025. All Rights Reserved by MedPath